Lytix Biopharma ASA (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 8.40
-0.06 (-0.71%)
Sep 18, 2026, 4:15 PM CET
Lytix Biopharma ASA Market Cap
Lytix Biopharma ASA has a market cap or net worth of 645.96 million as of September 18, 2026. Its market cap has increased by 23.22% in one year.
Market Cap
645.96M
Enterprise Value
556.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.40
ChartMarket Cap Chart
Since June 14, 2021, Lytix Biopharma ASA's market cap has decreased from 720.55M to 645.96M, a decrease of -10.35%. That is a compound annual growth rate of -2.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 645.96M | -4.22% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 3.14B |
| Thor Medical ASA | 2.00B |
| Nykode Therapeutics AS | 1.28B |
| ArcticZymes Technologies ASA | 1.06B |
| Oncoinvent ASA | 604.59M |
| Zelluna ASA | 602.98M |
| SoftOx Solutions AS | 301.29M |
| Arctic Bioscience AS | 72.78M |